Sou Hu Cai Jing·2025-08-21 13:01Core Viewpoint - China Petroleum & Chemical Corporation (Sinopec) reported a significant decline in revenue and net profit for the first half of 2025, attributed to external challenges such as falling international oil prices and low chemical market margins [1][2] Financial Performance - For the first half of 2025, Sinopec achieved operating revenue of RMB 1.41 trillion, a year-on-year decrease of 10.6% [1] - The net profit attributable to shareholders was RMB 21.483 billion, down 39.8% year-on-year [1] - The company maintained a cash dividend payout ratio of 49.7%, proposing a cash dividend of RMB 0.088 per share, totaling RMB 10.67 billion [1] Production and Operations - Sinopec's oil and gas equivalent production reached 262.81 million barrels, a 2.0% increase year-on-year [1] - Domestic crude oil production was 126.73 million barrels, while natural gas production was 736.28 billion cubic feet [1] - The company plans to produce 141 million barrels of crude oil and 714.5 billion cubic feet of natural gas in the second half of 2025 [2] Capital Expenditure - Sinopec announced a 5% reduction in its annual capital expenditure plan, with a focus on optimizing resource allocation [3] - Capital expenditures in the exploration and development sector will target projects in Jiyang and Taha, among others [3] Share Buyback Plan - The company plans to repurchase shares worth between RMB 500 million and RMB 1 billion, with a maximum buyback price of RMB 8.72 per share [4] - The expected number of shares to be repurchased ranges from approximately 57.34 million to 114.68 million, representing 0.05% to 0.09% of the total issued shares [4] Other Companies' Dividend Announcements - Other listed companies, including Dong'e Ejiao and Baichu Electronics, also announced significant interim dividend plans, with Dong'e Ejiao proposing a cash dividend of RMB 12.69 per 10 shares, totaling RMB 817 million, which is 117.01% of its net profit for the first half of 2025 [5] - Baichu Electronics plans to distribute RMB 6.66 per 10 shares, amounting to RMB 192 million, or 30.01% of its net profit [5] - Samsung Medical announced a cash dividend of RMB 4.85 per 10 shares, totaling approximately RMB 679 million, which is 55.20% of its net profit [5]